U.S. officials have authorized a new COVID-19 antibody drug for people with serious health problems or allergies who can’t get adequate protection from vaccination.
The Food and Drug Administration granted emergency use Wednesday to the drug combo made by AstraZeneca.
The drug could benefit cancer patients, organ transplant recipients and people with severe allergies to vaccinations. Health experts estimate about 2% to 3% of the U.S. population falls into that group.
Other antibody drugs are used to treat COVID-19 or prevent infection after possible exposure to the virus. The new AstraZeneca drug is intended for long-term prevention, not a treatment.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…